Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study

dc.contributor.author	Valladares Ayerbes, Manuel
dc.date.accessioned	2017-06-07T07:32:46Z
dc.date.available	2017-06-07T07:32:46Z
dc.date.issued	2012
dc.identifier.issn	1083-7159
dc.identifier.uri	http://hdl.handle.net/20.500.11940/7770
dc.language.iso	eng
dc.title	Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study
dc.type	Artigo	es
dc.authorsophos	Sastre, J.
dc.authorsophos	Maestro, M. L.
dc.authorsophos	Gomez-Espana, A.
dc.authorsophos	Rivera, F.
dc.authorsophos	Valladares, M.
dc.authorsophos	Massuti, B.
dc.authorsophos	Benavides, M.
dc.authorsophos	Gallen, M.
dc.authorsophos	Marcuello, E.
dc.authorsophos	Abad, A.
dc.authorsophos	Arrivi, A.
dc.authorsophos	Fernandez-Martos, C.
dc.authorsophos	Gonzalez, E.
dc.authorsophos	Tabernero, J. M.
dc.authorsophos	Vidaurreta, M.
dc.authorsophos	Aranda, E.
dc.authorsophos	Diaz-Rubio, E.
dc.identifier.doi	10.1634/theoncologist.2012-0048
dc.identifier.isi	WOS:000306821400011
dc.identifier.pmid	22643538
dc.identifier.sophos	7766
dc.issue.number	7
dc.journal.title	ONCOLOGIST
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	17

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.